Cancer cells often exhibit altered metabolic pathways to meet the high demand for nucleotides. They may upregulate both the de novo and salvage pathways of nucleotide biosynthesis. In the de novo pathway, nucleotides are synthesized from scratch using metabolic intermediates, while in the salvage pathway, cells recycle pre-existing nucleotides.
